Faes Farma S.A (FAE) | Stock Overview & Key Data

Faes Farma S.A. | Large-cap | Healthcare

€4.47

-1.32%

| Faes Farma S.A Stock Comparison:

Faes Farma S.A vs Laboratorios Faes Farma S.A vs Amadeus IT Faes Farma S.A vs Banco de Sabadell Faes Farma S.A vs Clinica Baviera S.A Faes Farma S.A vs Altia Consultores Faes Farma S.A vs IBEX 35 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Faes Farma S.A Performance Comparison

Loading chart data...

Faes Farma S.A

IBEX 35

View Full Price History

Stock Range

Today's Range

Low: €4.47 High: €4.55

on June 17, 2025

52 Week Range

Low: €3.27 High: €4.73

on March 17, 2025

on June 11, 2025

All-Time High: €19.40 on February 5, 2007

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €1.4B

EPS i 0.36

P/E Ratio (TTM) i 12.58

Forward P/E i 15.62

P/B Ratio i 1.94

PEG Ratio i 15.62

Div. Yield i 3.47%

ROE i 15.33%

Beta i 0.319

Debt to Equity i 3.62

Financial Highlights

Profitability

Gross Margin i 69.26%

Operating Margin i 21.89%

Profit Margin i 20.85%

Returns and Earnings

Return on Assets (TTM) i 13.05%

Return on Equity (TTM) i 15.33%

EBITDA i €155.4M

Net Income (TTM) i €109.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i €0.08

Estimated Dividend Yield i 1.81%

5 Year Average Dividend Yield i 4.05%

Last 12-Month Dividend Yield i 3.47%

Last 12-Month Dividend i €0.16

% of Earnings Paid as Dividends i 43.54%

Dividend Date i N/A

Ex-Dividend Date i January 9, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Faes Farma S.A FAE	1.41B Large-cap	4.93%	4.93%	35.45%	26.63%	27.35%	21.45%	20.80%	19.21%
Laboratorios ROVI	2.86B Large-cap	0.54%	6.45%	6.95%	-10.94%	-12.27%	-35.71%	-1.24%	132.50%
Amadeus IT AMS	30.83B Large-cap	-3.45%	-0.25%	1.23%	6.24%	5.19%	10.06%	34.59%	40.37%
Banco de Sabadell SAB	14.52B Large-cap	1.07%	4.03%	4.03%	46.39%	52.69%	59.77%	247.50%	742.42%
Clinica Baviera S.A CBAV	617.34M Mid-cap	-8.37%	3.14%	10.99%	21.98%	25.08%	38.85%	90.15%	291.88%
Altia Consultores ALC	429.03M Mid-cap	0.00%	7.76%	30.21%	36.46%	38.89%	32.98%	-75.39%	-65.08%

Ownership & Short Interest

Insider Ownership i 13.34%

Institutional Ownership i 19.95%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 223K

Average 90-Day Volume i 209K

Faes Farma S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Faes Farma S.A would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is FAE's 52-week high and low?

In the last 52 weeks, Faes Farma S.A reached a high of €4.73 (on June 11, 2025) and a low of €3.27 (on March 17, 2025).

What is the market cap and P/E ratio for FAE?

Curious about Faes Farma S.A's size and valuation? Its market capitalization stands at 1.41B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.58, and the forward P/E (looking ahead) is 15.62.

Does FAE pay dividends? If so, what's the yield?

Yes, Faes Farma S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.47%, and the company is expected to pay out €0.08 per share over the coming year.

Who are Faes Farma S.A's main competitors or similar companies to consider before investing?

When looking at Faes Farma S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Laboratorios ROVI	2.86B	Healthcare	Drug Manufacturers - Specialty & Generic	-35.71%	-1.24%
Amadeus IT AMS	30.83B	Healthcare	Medical Care Facilities	10.06%	34.59%
Banco de Sabadell SAB	14.52B	Healthcare	Diagnostics & Research	59.77%	247.50%
Clinica Baviera S.A CBAV	617.34M	Healthcare	Diagnostics & Research	38.85%	90.15%
Altia Consultores ALC	429.03M	Healthcare	Medical Instruments & Supplies	32.98%	-75.39%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Faes Farma S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Faes Farma S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.33%, the Debt to Equity ratio from the most recent quarter is 3.62, and its Gross Profit Margin stands at 69.26%.

What is the recent revenue and earnings growth for FAE?

Looking at Faes Farma S.A's growth, its revenue over the trailing twelve months (TTM) was €524M. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.10%, and quarterly earnings saw a YoY growth of -6.90%.

How much of FAE stock is held by insiders and institutions?

Wondering who owns Faes Farma S.A stock? Company insiders (like executives and directors) hold about 13.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 19.95%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.